|
|
Office Locations:
|
P.O. Box 60207
Potomac, MD 20859
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
jVen is a privately held life sciences investment management company. jVen is a venture capital and growth equity investor with a focus in the areas of personalized medicine, genetics, and medical devices. The firm was established in 2007 by Evan Jones, a successful entrepreneur in the life sciences and molecular diagnostics fields. Prior to forming jVen Capital Mr. Jones was co-founder, Chairman and CEO of Digene Corporation, a publicly traded biotechnology company focused on womens health and molecular diagnostic testing.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
